As of 2025-06-16, the Relative Valuation of Accelerate Diagnostics Inc (AXDX) is (216.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.03 USD, the upside of Accelerate Diagnostics Inc based on Relative Valuation is -637739.7%.
The range of the Relative Valuation is (215.37) - (218.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.4x - 43.0x | 37.8x |
| Forward P/E multiples | 33.4x - 35.9x | 33.6x |
| Fair Price | (215.37) - (218.29) | (216.80) |
| Upside | -633539.4% - -642118.7% | -637739.7% |
| Date | P/E |
| 2025-06-05 | -0.00 |
| 2025-06-04 | -0.00 |
| 2025-06-03 | -0.00 |
| 2025-06-02 | -0.00 |
| 2025-05-30 | -0.00 |
| 2025-05-29 | -0.00 |
| 2025-05-28 | -0.00 |
| 2025-05-27 | -0.00 |
| 2025-05-23 | -0.00 |
| 2025-05-22 | -0.00 |
| 2025-05-21 | -0.00 |
| 2025-05-20 | -0.00 |
| 2025-05-19 | -0.00 |
| 2025-05-16 | -0.00 |
| 2025-05-15 | -0.01 |
| 2025-05-14 | -0.01 |
| 2025-05-13 | -0.01 |
| 2025-05-12 | -0.02 |
| 2025-05-09 | -0.02 |
| 2025-05-08 | -0.02 |
| 2025-05-07 | -0.08 |
| 2025-05-06 | -0.08 |
| 2025-05-05 | -0.09 |
| 2025-05-02 | -0.09 |
| 2025-05-01 | -0.08 |
| 2025-04-30 | -0.09 |
| 2025-04-29 | -0.09 |
| 2025-04-28 | -0.09 |
| 2025-04-25 | -0.10 |
| 2025-04-24 | -0.09 |
| 2025-04-23 | -0.09 |
| 2025-04-22 | -0.09 |
| 2025-04-21 | -0.09 |
| 2025-04-17 | -0.09 |
| 2025-04-16 | -0.09 |
| 2025-04-15 | -0.09 |
| 2025-04-14 | -0.09 |
| 2025-04-11 | -0.09 |
| 2025-04-10 | -0.10 |
| 2025-04-09 | -0.10 |
| 2025-04-08 | -0.10 |
| 2025-04-07 | -0.10 |
| 2025-04-04 | -0.11 |
| 2025-04-03 | -0.11 |
| 2025-04-02 | -0.12 |
| 2025-04-01 | -0.12 |
| 2025-03-31 | -0.12 |
| 2025-03-28 | -0.12 |
| 2025-03-27 | -0.14 |
| 2025-03-26 | -0.14 |